Accretion Pharmaceuticals Ltd
company logo

Accretion Pharmaceuticals Ltd

AccretionPha. Share Price

BSE:94000

NSE:ACCPL

70

0.30 (0.43%)

As on April 2, 2026 at 04:14 PM
Loading chart...

Performance

Loading performance...

69.70

66.70

18000

0.13

10

Fundamentals

77.81Cr

11.46

1.73

1.33

6.11

0%

40.52

About

Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products. Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in 2014. Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies. Presently, Company is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. either for direct sales, loan licence and/or contract manufacturing. The Company is ISO 9001:2015, ISO 14001:2015 and ISO 22000:2018 certified and is led by a experienced board of directors, and a professional and experienced management team with extensive experience in the pharmaceutical. The Company issued and allotted 29,46,000 equity shares of Rs 10 each by raising Rs 29.75 crores in May, 2025.

Vivek Ashok Kumar Patel

2023

ACCPL

NameDesignation
Mayur Popatlal SojitraExecutive Director
Harshad Nanubhai RathodChairman & CFO
Vivek Ashok Kumar PatelManaging Director
Hardik Mukundbhai PrajapatiExecutive Director
Grishma A ShewaleIndependent Director
Bhavika Dhaval MakadiaCompany Sec. & Compli. Officer
Chand Rameshbhai KanabarIndependent Director
Nishtha Harivanshi PamnaniIndependent Director

Accretion Pharmaceuticals Ltd FAQs

How do I Buy Accretion Pharmaceuticals Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Accretion Pharmaceuticals Ltd shares in BlinkX.

What is the Share Price of Accretion Pharmaceuticals Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Accretion Pharmaceuticals Ltd's share price is ₹70 as of 2026-04-02.

What is the PE ratio of Accretion Pharmaceuticals Ltd?

close

Accretion Pharmaceuticals Ltd's P/E ratio is 11.46 times as of 2026-04-02.

What is the PB ratio of Accretion Pharmaceuticals Ltd?

close

Accretion Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 1.73, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Accretion Pharmaceuticals Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Accretion Pharmaceuticals Ltd's market capitalization is ₹77.81 Cr as on 2026-04-02.

What is the ROE of Accretion Pharmaceuticals Ltd?

close

The current financial records of Accretion Pharmaceuticals Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Accretion Pharmaceuticals Ltd?

close

According to Accretion Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹33.55, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Accretion Pharmaceuticals Ltd?

close

The 52-week high/low price of a Accretion Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Accretion Pharmaceuticals Ltd's 52-week high and low as of 2026-04-02 are ₹102.5 and ₹53.8, respectively.